The SynVivo platform has been validated for accurate prediction of in vivo responses. Use this unique in vitro platform for realistic assessment of drug delivery, analysis of cell-cell, cell-drug, and their underlying mechanisms. Recreate cellular and tissue architecture in a Organ-on-Chip format compatible with standard analytical instrumentation. With simultaneous visualization and real-time monitoring of cellular and tissue architecture of desired organs, the SynVivo platform enables identification of toxicity responses to reduce expensive and time-consuming preclinical or clinical trials.
Our assays provide a unique perspective of the realism of an in vivo microenvironment in an in vitro environment for modeling drug delivery, drug discovery, and ADME/Toxicity. Screening Services include target validation, compound screening, biomarker analysis, ADME/Tox, and mechanism of action studies.
Services are offered using our validated 3D tissue models and we also provide custom assay development specifically tailored to meet your goals. Assay Development services can be performed to develop new 3D Tissue and Organ on-Chip models, end-points, or custom chip designs. Our team of engineers and scientists will work closely with your team for the adaptation of the SynVivo platform to develop the right solution for your application.
